Seonix Bio SightScore

Seonix Bio of San Diego has launched SightScore, a clinical polygenic risk score testing service for glaucoma, in the US. Using a saliva sample, the test analyzes millions of genetic variants to estimate a person's genetic risk of developing glaucoma or the risk of a glaucoma patient's condition worsening, the company said. SightScore can be referred online by an appropriate health professional.